Methylene blue photodynamic therapy of antifungal-unresponsive (resistant) dermatophytosis
This study was an exploratory, single-centre, open-label, uncontrolled investigation of methylene blue photodynamic therapy (MB-PDT) for the treatment of antifungal-resistant dermatophytosis. One-third of participants with antifungal-resistant dermatophytosis responded to two sessions of MB-PDT therapy. The small sample size and limited number of treatment sessions were possibly insufficient to investigate the true potential of this approach.
Authors
- Pernille Lindsø Andersen (ORCID: https://orcid.org/0000-0002-0132-4715)
- Ditte Marie Lindhardt Saunte (ORCID: https://orcid.org/0000-0001-7953-1047)
- Gregor B. E. Jemec (ORCID: https://orcid.org/0000-0002-0712-2540)
- Maiken Cavling Arendrup (ORCID: https://orcid.org/0000-0002-4747-0144)
Institutions
- Statens Serum Institut (DK)
- University of Copenhagen (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- Zealand University Hospital (DK)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1093/bjd/ljaf258
- Primary Topic
- Nail Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00